Home › NDC Lookup › RxCUI directory › RxCUI 239200

Chloramphenicol 100 MG/ML Injectable Solution — RxCUI 239200

RxNorm drug concept · Semantic clinical drug
RxCUI 239200 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI239200
Official nameChloramphenicol 100 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aschloramphenicol (as chloramphenicol sodium succinate) 1 GM per 10 ML Powder for Injectable Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)32 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Chloramphenicol Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Chloramphenicol carries a risk of causing aplastic anemia — a serious, sometimes fatal condition where your bone marrow stops making blood cells. Because safer antibiotics exist fo...
  • Why is this antibiotic only used for serious infections? Why not just use it for any bacterial infection?
  • Aplastic anemia is a condition where the bone marrow — the spongy tissue inside your bones — stops producing enough red blood cells, white blood cells, and platelets. Warning signs...
  • What is aplastic anemia, and how would I know if I was developing it?
📖 Read our full Chloramphenicol Injection guide →

🕸️ Concept Web — How Chloramphenicol 100 MG/ML Injectable Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Chloramphenicol 100 MG/ML Injectable Solution RxCUI 239200

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Chloramphenicol 2348
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Chloramphenicol Injectable Solution 370500
    • Chloramphenicol Injectable Product 1153057
    • Injectable Solution 316949
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Chloramphenicol 100 MG/ML 332756

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Chloramphenicol 100 MG/ML SCDC · 332756
  • Chloramphenicol Injectable Solution SCDF · 370500
  • Chloramphenicol Injectable Product SCDG · 1153057

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 239200 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63323-0011-15 10 VIAL in 1 TRAY (63323-011-15) / 10 mL in 1 VIAL Chloramphenicol Sodium Succinate Fresenius Kabi USA, LLC 2001-01-12
Observed labelers: Fresenius Kabi USA, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.